Evidence map›Paper›PMID 24307814›Full record

ArticleWorld journal of gastroenterology2013

Hydroxycitric acid does not promote inflammation or liver toxicity.

Dallas L Clouatre, Harry G Preuss

Open access · hybridAbstract readLetterComment
In one paragraph

Article in World journal of gastroenterology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Food & nutrition research · 2023
    Article
  3. Antioxidants (Basel, Switzerland) · 2021
    Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Dangerous dietary supplements:World journal of gastroenterology · 2016
    Article
  10. Article
  11. Effect of orlistat alone or in combination withJournal of intercultural ethnopharmacology
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Dallas L ClouatreDallas L Clouatre, Glykon Technologies Group, LLC, Seattle, WA 98109, United States.
Harry G Preuss
Critical Technologies (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Garcinia cambogia extract (GC) with its active component consisting of hydroxycitric acid (HCA) is widely utilized for weight loss. Various HCA salts are available, including calcium, magnesium, potassium and mixtures of these. Experimentally, these salts exhibit different properties with some, but not all, improving glucose tolerance and blood pressure. Recently, obesity-prone C57BL/6J mice were fed a high-fat diet (HFD, 45 kcal% fat) with or without GC (1%, w/w) for 16 wk. The active arm reduced visceral fat, adipocyte size and serum glucose, yet purportedly also exhibited hepatic collagen accumulation, lipid peroxidation and increased mRNA levels of genes related to oxidative stress. The latter findings are at odds with a large body of animal and human studies that have been conducted on the safety and efficacy of HCA. This literature shows HCA to be protective against the liver toxicity associated with ethanol and dexamethasone administration, and to maintain serum aspartate aminotransferase, alanine aminotransferase and alkaline phosphatase at near normal levels. In both animal and clinical literature, elevated intakes of HCA per se have not led to signs of inflammation or hepatotoxicity. The compound has been found to reduce markers of inflammation in brain, intestines, kidney and serum.

Indexed as

Garcinia cambogiaAdiposityAnimalsAnti-Obesity AgentsChemical and Drug Induced Liver InjuryFatty LiverIntra-Abdominal FatLiverLiver Cirrhosis, ExperimentalMaleObesityPlant ExtractsAnti-Obesity AgentsPlant ExtractsGarcinia cambogiaHepatic collagenHepatic inflammationHepatic oxidative stressHydroxycitric acidMetabolic syndromeTumor necrosis factor-αWeight loss

Identifiers

PMID24307814
PMCPMC3848168
OpenAlexW2031106515

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.